NL8202636A - Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. - Google Patents

Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. Download PDF

Info

Publication number
NL8202636A
NL8202636A NL8202636A NL8202636A NL8202636A NL 8202636 A NL8202636 A NL 8202636A NL 8202636 A NL8202636 A NL 8202636A NL 8202636 A NL8202636 A NL 8202636A NL 8202636 A NL8202636 A NL 8202636A
Authority
NL
Netherlands
Prior art keywords
compound
formula
group
fluorophenyl
piperazine
Prior art date
Application number
NL8202636A
Other languages
English (en)
Dutch (nl)
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Priority to NL8202636A priority Critical patent/NL8202636A/nl
Priority to JP58111752A priority patent/JPS5920275A/ja
Priority to PT76909A priority patent/PT76909B/pt
Priority to DE8383200941T priority patent/DE3375690D1/de
Priority to EP83200941A priority patent/EP0099148B1/de
Priority to AT83200941T priority patent/ATE32512T1/de
Priority to DK297383A priority patent/DK297383A/da
Priority to GR71785A priority patent/GR77523B/el
Priority to ES523689A priority patent/ES523689A0/es
Priority to US06/509,168 priority patent/US4476129A/en
Publication of NL8202636A publication Critical patent/NL8202636A/nl
Priority to ES533068A priority patent/ES8507130A1/es
Priority to ES533069A priority patent/ES8502982A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL8202636A 1982-06-29 1982-06-29 Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. NL8202636A (nl)

Priority Applications (12)

Application Number Priority Date Filing Date Title
NL8202636A NL8202636A (nl) 1982-06-29 1982-06-29 Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
JP58111752A JPS5920275A (ja) 1982-06-29 1983-06-21 ピペラジン誘導体、その製造法並びにこれらを含有する薬剤処方物
PT76909A PT76909B (en) 1982-06-29 1983-06-21 Piperazine derivatives processes for their preparation and pharmaceutical preparations containing them
AT83200941T ATE32512T1 (de) 1982-06-29 1983-06-23 Piperazinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP83200941A EP0099148B1 (de) 1982-06-29 1983-06-23 Piperazinderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE8383200941T DE3375690D1 (en) 1982-06-29 1983-06-23 Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
DK297383A DK297383A (da) 1982-06-29 1983-06-28 Fremgangsmaade til fremstilling af piperazinderivater
GR71785A GR77523B (de) 1982-06-29 1983-06-28
ES523689A ES523689A0 (es) 1982-06-29 1983-06-29 Procedimiento para preparar derivados de piperazina.
US06/509,168 US4476129A (en) 1982-06-29 1983-06-29 4-[2-[Bis(halophenyl)methoxy]-ethyl]-α-(substituted phenyl)-1-piperazinealkanol derivatives, processes for their preparation and pharmaceutical preparations containing them
ES533068A ES8507130A1 (es) 1982-06-29 1984-06-01 Procedimiento para preparar derivados de piperazina
ES533069A ES8502982A1 (es) 1982-06-29 1984-06-01 Procedimiento para preparar derivados de piperazina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8202636A NL8202636A (nl) 1982-06-29 1982-06-29 Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
NL8202636 1982-06-29

Publications (1)

Publication Number Publication Date
NL8202636A true NL8202636A (nl) 1984-01-16

Family

ID=19839950

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8202636A NL8202636A (nl) 1982-06-29 1982-06-29 Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.

Country Status (10)

Country Link
US (1) US4476129A (de)
EP (1) EP0099148B1 (de)
JP (1) JPS5920275A (de)
AT (1) ATE32512T1 (de)
DE (1) DE3375690D1 (de)
DK (1) DK297383A (de)
ES (3) ES523689A0 (de)
GR (1) GR77523B (de)
NL (1) NL8202636A (de)
PT (1) PT76909B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
US5001160A (en) * 1988-04-28 1991-03-19 Marion Laboratories, Inc. 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
WO1990013539A1 (en) * 1989-04-28 1990-11-15 Meiji Seika Kaisha, Ltd. New n-substituted piperazine derivatives and drug for improving functional disorder of brain
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
JP2001506978A (ja) 1996-10-31 2001-05-29 アメリカ合衆国 置換１―［２［ビス（アリール）メトキシ］エチル］―ピペラジンおよび―ホモピペラジンのヒドロキシル化類似物の持続性放出誘導体およびそのドパミン再アップテイクの非競合的拮抗物質としての使用
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
CN1181065C (zh) * 2002-05-08 2004-12-22 上海医药工业研究院 芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
GB0220214D0 (en) * 2002-08-30 2002-10-09 Novo Pharmaceuticals De Ltd Compounds and their use
AU2003300147A1 (en) * 2003-01-06 2004-08-10 The General Hospital Corporation Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
US7381822B2 (en) * 2004-03-31 2008-06-03 The General Hospital Corporation Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
AU2008251259B2 (en) * 2007-05-14 2013-02-14 Sk Biopharmaceuticals Co., Ltd. Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9056859B2 (en) 2010-10-29 2015-06-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2744499B1 (de) 2011-08-19 2016-09-28 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
TW201317213A (zh) 2011-09-16 2013-05-01 Merck Sharp & Dohme 腎外髓質鉀通道抑制劑
WO2013062892A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8999991B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773206B1 (de) 2011-10-31 2018-02-21 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US9139585B2 (en) 2011-10-31 2015-09-22 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
WO2013066718A2 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013090271A1 (en) 2011-12-16 2013-06-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
WO2014059346A1 (en) * 2012-10-11 2014-04-17 Brown Arthur M Methods for the treatment of conditions involving dopamine through administration of piperazine compounds
WO2014059367A1 (en) * 2012-10-11 2014-04-17 Chanrx Corporation Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions
WO2014059338A1 (en) * 2012-10-11 2014-04-17 Chanrx Corporation Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
EP2925322B1 (de) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
EP2934533B1 (de) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitoren des kaliumkanals des äusseren nierenmarks
US9604998B2 (en) 2013-02-18 2017-03-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2968288B1 (de) 2013-03-15 2018-07-04 Merck Sharp & Dohme Corp. Inhibitoren des renalen kaliumkanals der äusseren medulla
US20160304477A1 (en) * 2013-04-26 2016-10-20 Laguna Pharmaceuticals, Inc. Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015073967A1 (en) * 2013-11-15 2015-05-21 Brown Arthur M Novel metabolites of vanoxerine compounds for the treatment of dopaminergic diseases
CN108329282B (zh) * 2018-01-16 2022-01-07 新乡医学院 一种苯基哌嗪类衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2350100A1 (fr) * 1976-05-06 1977-12-02 Sauba Lab Derives disubstitues de la piperazine, leur procede de preparation et leurs applications therapeutiques
FR2374318A1 (en) * 1976-12-14 1978-07-13 Gist Brocades Nv 1-Benzhydryl:oxy-alkyl-4-phenylalkyl- or cinnamyl-piperazine derivs. - with dopaminergic, anticholinergic and antiparkinson activity (BE 14.6.78)
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives

Also Published As

Publication number Publication date
GR77523B (de) 1984-09-24
ES8500252A1 (es) 1984-10-01
DE3375690D1 (en) 1988-03-24
ES533068A0 (es) 1985-08-16
ES533069A0 (es) 1985-02-01
PT76909A (en) 1983-07-01
JPS5920275A (ja) 1984-02-01
EP0099148A1 (de) 1984-01-25
DK297383A (da) 1983-12-30
ES8502982A1 (es) 1985-02-01
DK297383D0 (da) 1983-06-28
EP0099148B1 (de) 1988-02-17
ES8507130A1 (es) 1985-08-16
ATE32512T1 (de) 1988-03-15
PT76909B (en) 1986-01-24
US4476129A (en) 1984-10-09
ES523689A0 (es) 1984-10-01

Similar Documents

Publication Publication Date Title
NL8202636A (nl) Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
AU604027B2 (en) Amide derivatives
JP3880842B2 (ja) １−〔（４−クロロフェニル）フェニルメチル〕ピペラジンの鏡像体およびその製造法
JP4790969B2 (ja) ペルオキシソーム増殖剤応答性受容体δの活性化剤
JP4809338B2 (ja) 新規なヘキサフルオロイソプロパノール誘導体
FR2735127A1 (fr) Nouvelles piperazines heteroaromatiques utiles comme medicaments.
HU207988B (en) Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
FR2722788A1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
KR20070046849A (ko) 신규한 티오펜 유도체
EP1851210B1 (de) Nitrosubstituierte phenylpiperazinverbindungen, deren herstellung und deren verwendung in medikamenten
JPH02262552A (ja) プロペノンオキシムエーテル類、その製造方法、並びにこれを含有する調剤組成物
JP5852269B2 (ja) Ｍｏｇａｔ−２阻害剤として有用な新規モルホリニル誘導体
AU617530B2 (en) (diarylmethoxy)-1-pyrrolidines and-piperidines
JPH0723364B2 (ja) 新規な１−ピペラジンカルボキサミド誘導体
CA2145026A1 (fr) Aminoalkyl benzoxazolinones et benzothiazolinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR20010072775A (ko) 항당뇨병성 피페라진 유도체, 이들 제제의 제조방법 및이를 함유하는 조성물
JPWO2006126714A1 (ja) ペルオキシソーム増殖剤活性化受容体の活性化剤
WO1994002473A1 (fr) Derives de la n-cycloalkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant
FR2761064A1 (fr) Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments
FR2731222A1 (fr) Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
CA2142535A1 (en) 1-[2-(1h-inden-3-yl)ethyl]-4- (naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics
JPH0680645A (ja) アルキレンジアミン誘導体
JPS588061A (ja) 新規なベンゾイル―フェニル―ピペラジン誘導体、該誘導体を含有する免疫療法剤および該誘導体の製法
CA1070689A (en) 2-(2-hydroxyethyl) tetrahydro-1,4 oxazines and quaternary salts thereof useful for treating spasmodic syndromes
AU648126B2 (en) Amino alkyl keto thienyl derivatives, processes for preparing them and their use as peripheral vasodilators

Legal Events

Date Code Title Description
A1B A search report has been drawn up
A85 Still pending on 85-01-01
BV The patent application has lapsed